New chip and glasses system restores vision for people with macular degeneration in the US, Europe, and the UK

A new implantable chip and special glasses system, Prima, has shown significant success in restoring vision for patients with age-related macular degeneration (AMD). The Prima system, tested across multiple countries, improved central vision in over 80% of participants, enabling them to read and significantly enhancing their reading ability. This technology offers hope for millions affected by AMD, a leading cause of vision loss in older adults, and is seeking regulatory approval for wider use.